ARE TREATMENTS OVERSEEN BY A MEDICAL DOCTOR?
Yes, as a medical requirement, treatments at BLOOMSKIN are overseen by our medical doctor who is a member of NZSCM.
Payments can be made by Eftpos, credit card or GenoaPay.
CAN I RETURN TO WORK AFTER MY TREATMENT?
Yes, certainly! Some treatments result in redness or swelling to the site, occasionally people experience mild bruising. Ice packs are applied to minimise these risks.
WHAT ARE DERMAL FILLERS?
Dermal fillers are hydrating treatments used to can contour and create volume, fill out lines and wrinkles, and revitalise the skin. Those used at BLOOMSKIN are chosen for their quality, are
temporary and dissolvable, and made up of Hyaluronic Acid (HA), a substance that naturally exists in your body. Results are visible immediately and can last for around 9 – 18 months.
COMMON AREAS TREATED WITH DERMAL FILLERS?
• Nose to mouth lines (the nasolabial folds)
• Corners of the mouth (marionette lines)
• Lip augmentation
• Cheek Augmentation
• Ear Lobes
IS THERE ANY DOWN TIME AFTER FILLER TREATMENT?
Dermal filler products will naturally metabolise over time, without harm. An optimal and long-lasting result may require a top-up treatment, but this will be discussed with you at the time. Some reactions may occur slight redness, swelling, itching, bruising, discomfort and tenderness. The reactions are
generally mild to moderate and usually disappear shortly after injection. They typically resolve spontaneously within one or two days, but for some treatments they may last longer.
CAN EVERYBODY USE DERMAL FILLERS?
Yes, apart from those previously allergic to hyaluron, pregnant or breastfeeding, with permanent fillers of facial implants, unwell with a cold, sinusitis or a facial infection, prior keloid scarring, less than a month after deep skin resurfacing, planned dental treatment in a month or flying overseas (in or under 4 days). Caution is needed in those with auto-immune disorders.
WHAT ARE THE NEUROMODULATORS, BOTOX® AND XEOMIN®?
Botox® and Xeomin® injections are a natural, purified protein that relaxes wrinkle-causing muscles, creating a smoothed and improved appearance. Botulinum Type A Neurotoxin Botox® and Xeomin® is produced by the bacterium Clostridium. Botulinum and has an interesting history, being used in humans for the treatment of strabismus (“crossed-eyes”) in 1978. These days, Botox® and Xeomin® is used to treat a variety of medical conditions such as migraine, excessive sweating, cerebral palsy, back and facial spasms as well as the treatment of facial wrinkles. Wrinkle relaxing injections using Botox® and Xeomin® is a well-studied treatment with an established safety profile and is a natural, purified protein derived in a controlled fashion from bacteria, such as penicillin.
Botox® and Xeomin® and similar neuromodulators are the only medical products of their type with more than twenty years of usage involving millions of patients worldwide, comprehensive clinical trials, published studies and extensive clinical practice.
Botox® and Xeomin®are among one the most widely researched medicines in the world, approved for use in over 75 countries.
Wrinkle relaxing injections using these neuromodulators are simple, quick and minimally invasive treatments that deliver fast, visible results.
HOW DO BOTOX® AND XEOMIN® WORK?
Botulinum (Botox® and Xeomin®) work by blocking the impulses from the nerves that control muscle movement. When injected into muscle tissue, muscles relax usually after several days, meaning the muscles are unable to contract or bunch up. In turn, a smooth rejuvenated appearance of the skin occurs; this can last from three to five months which is generally dependent on which muscles have been injected and their frequency of use.
WHO SHOULD NOT HAVE BOTOX® AND XEOMIN®?
• Patients with neuromuscular disorders such as myesthenia
gravis should not be treated with Botulinum.
• True allergic reactions to Botulinum have not been observed.
• Pregnant or nursing women.
IS THERE DOWNTIME AFTER TREATMENT WITH BOTOX® AND XEOMIN®?
Usually not. Immediately after treatment you may notice slight pinkness to the skin where the needle has been introduced. This may last ten minutes and quickly disperses.
BOTOX® is a Prescription Medicine containing 100 units of botulinum toxin type A for injection. It is used for the treatment of frown lines, forehead lines and crow’s feet. It should be administered only by trained medical professionals. Ask your specialist about the benefits and risks of using Botox and whether Botox is right for you. If you have any side effects or concerns speak to your health professional. You will need to pay for Botox. Botox has benefits and risks. Always follow your specialist’s instructions. For more information refer to the Consumer Medicine Information for Botox at www.medsafe.govt.nz
BOTOX® is a registered trademark of Allergan, Inc. Allergan New Zealand Ltd, PO Box 1873, Shortland Street, Auckland 1140, New Zealand.
Xeomin® (Incobotulinumtoxin A) 50, 100 Units is a Prescription Medicine. Indications:
In adults, for the treatment of cervical dystonia; blepharospasm; spasticity of the upper limb; upper facial lines: glabellar frown lines, lateral periorbital lines (crow’s feet), horizontal forehead lines. Xeomin® has both risks and benefits, consult your doctor if Xeomin® is right for you. Further information on the risks and benefits of Xeomin® can be found in the Consumer Medicine Information (CMI) available from www.merzaustralia.com.au/our-competencies/aesthetics/products/ or by calling 0800 822 310. Use strictly as directed. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. Common side effects include:
Headaches; nausea; tenderness, swelling, redness, numbness or bruising of the skin; dry eye; heavy feeling of eyelid/eyebrow/forehead; face/brow not symmetrical, dropping eyelids/eyebrows and allergic reaction. Xeomin® is an unfunded medicine, prescription charge will apply. Normal doctor charges will still apply.
Pharmacy Retailing NZ Limited t/a Healthcare Logistics (HCL), 58 Richard Pearse Drive, Mangere, Auckland 2022. Medical information: Ph: 0800 822 310. All rights reserved. Xeomin® and Merz Aesthetics are registered trademarks of Merz Pharma GMbH & Co. KGaA. Copyright © 2019. NZL_XEOMIN_MALE_V1_JAN19. Date of preparation: JAN 2019. 8057MER
The JUVÉDERM® range of injectable gels are medical devices for use in adults. JUVÉDERM® ULTRA XC and
JUVÉDERM® ULTRA PLUS XC contain 24mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL. JUVÉDERM® ULTRA XC is for filling medium-sized depressions of the skin as well as for lip definition. JUVÉDERM® ULTRA PLUS XC is for filling mid and/or deep depressions of the skin as well as for lip definition and enhancement. JUVÉDERM® VOLUMA® with lidocaine contains 20mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended to restore volume of the face. JUVÉDERM® VOLIFT® with lidocaine contains 17.5mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended for the treatment of deep skin depressions, for face contouring or volume restoration of the face. JUVÉDERM® VOLBELLA® with lidocaine contains 15mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended for the treatment of any fine lines and medium-sized skin depressions or the enhancement and pouting of lips. JUVEDERM® VOLITE™ contains 12 mg/mL cross-linked hyaluronic acid with lidocaine 3mg/mL and is intended to be used for the treatment, by filling, of superficial cutaneous depressions such as fine lines and for additional improvement of skin quality attributes such as hydration and elasticity, via intradermal injection. All JUVÉDERM® products should be administered only by a trained healthcare professional. JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC and JUVEDERM® VOLITE™ should not be injected into the eyelids. JUVÉDERM® VOLUMA® with lidocaine should not be injected in the periorbital area (eyelids, under-eye area, crow’s feet), glabellar region or in the lips. JUVÉDERM® VOLBELLA® with lidocaine should not be injected into the eyelids. Application in the bags under the eyes is reserved for trained specialists. JUVÉDERM® VOLIFT® with lidocaine should not be injected in the periorbital area (eyelids, under-eye area, crow’s feet) and glabellar region. You should not receive treatment with any JUVÉDERM® product if you are below 18 years of age, have untreated epilepsy, history of hypertrophic scars or porphyria, or if you are pregnant or breastfeeding, hypersensitivity to ingredients including hyaluronic acid, lidocaine or amide-type local anaesthetics, any areas of cutaneous inflammation and/or infections, or if you have just had laser treatment, deep chemical peel or dermabrasion. Precautions: Caution is required if you have received treatment with another dermal filler; if you have a history of or are currently suffering an auto-immune disease, severe multiple allergies, anaphylactic shock, streptococcal disease, symptoms of cardiac conduction disorders; or if you are taking certain medications including anti-coagulants or certain drugs that reduce/inhibit hepatic metabolism. Avoid makeup for 12 hours after injection and prolonged exposure to sunlight/UV light/extreme temperatures for 2 weeks. Adverse effects reported after treatment with JUVÉDERM® range of fillers have included immediate or delayed injection site inflammatory reactions (redness/swelling/ itching/pain on pressure) persisting a week post treatment, haematomas, induration or nodules, discolouration, weak filling effect, risk of infection, abscess formation, granuloma, necrosis or hypersensitivity. Please ask your doctor or request for the Directions For Use for complete list of precautions and adverse effects per respective filler. JUVÉDERM® injectable gels are not funded on the New Zealand Pharmaceutical Scheme. You will need to pay for this treatment. Normal Doctors visit fees apply. Speak to your specialist about your own situation and about the benefits/ risks of this procedure in appearance medicine. If you have any side effects or concerns speak to your doctor. Note: JUVÉDERM® treatment may last up to 1–2 years and further courses of treatment may be necessary. (September 2018).
™®Trademark(s) and registered trademark(s) of Allergan, Inc. Allergan Australia Pty Ltd. 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan. All rights reserved. Date of preparation: October 2018 ANZ/0104/2017.
Restylane® Consumer Mandatory
Restylane® is an unfunded Treatment that you pay for. Ask your Doctor if Restylane is right for you. Normal Doctors charges apply. Restylane is an injectable intradermal implant containing Hyaluronic acid, stabilized 20 mg/ml
RESTYLANE® used for facial tissue augmentation and lip enhancement.
Restylane should only be injected by your doctor. Tell your doctor if you have a bleeding disorder or if you are being treated with blood thinning medicines, or any other medicines you are taking.Precautions : Allergy to Hyaluronic acid or any active ingredients. RESTYLANE® should not be used where there is active skin disease, inflammation or related conditions. Do not use if pregnant or breastfeeding, or in children. Avoid intense heat or cold after treatment until swelling and redness have resolved.Side effects: common injection-related reactions might occur, including redness, swelling, pain, itching, bruising, tenderness or lumpiness at the implant site. Typically these resolve in a few days to a week. Tell your doctor if you experience any side effects. For further information ask your doctor .Restylane is marketed by Q-Med and distributed in NZ by Pharmacy Retailing (NZ) t/a Healthcare Logistics, Auckland
Belotero® is a MedSafe WAND notified Medical Device Class III. Always read the label and follow instructions. Belotero® is a gel that is injected by a healthcare professional into or below the skin to smooth facial wrinkles and folds, correct facial atrophic scars, restore or enhance the lips or restore facial volume such as in the cheeks and chin. Use with caution in patients taking antithrombotic medications or methemoglobin-inducing agents, active autoimmune disease, epilepsy, porphyria, impaired cardiac, hepatic or renal function or anyone with a history of multiple allergies, anaphylaxis, streptococcal diseases or predisposed to cheloids or hypertrophic scars. Use in the nose or periorbital area should only be performed by a trained experienced practitioner. After Belotero® treatment patients may experience redness, swelling, pain, itching and/or bruising which may last up to a week. Discuss with your specialist if Belotero® is right for you. For more information please contact the New Zealand Distributor: New Zealand Medical & Scientific Ltd, 2a Fisher Crescent, Mt Wellington, Auckland, Phone 09 259 406